Entity

Time filter

Source Type

Xizhi District, Taiwan

The present invention provides a process for the preparation of


Patent
Development Center For Biotechnology and DCB United States LLC | Date: 2014-04-18

A humanized antibody, or a scFv, Fab, or F(ab)


Patent
Development Center For Biotechnology | Date: 2014-12-29

A method for recombinant production of a CRM197 protein includes culturing a recombinant


Patent
Development Center For Biotechnology | Date: 2014-12-22

A method for treating an inflammatory disease or an immune disorder includes administering to a subject in need of such treatment an antagonist against ENO1. The antagonist binds ENO1 and inhibits ENO1 plasminogen receptor activity. The antagonist may be an anti-human ENO1 antibody, or an scFv, Fab, or F(ab)


Patent
Development Center For Biotechnology | Date: 2013-12-31

An anti-granulysin antibody, or an scFv or Fab fragment thereof, capable of binding to an epitope region from R64 to R113 of granulysin and capable of neutralizing an activity of granulysin. The antibody may contain a sequence selected from the sequences of SEQ ID NO:82 to SEQ ID NO:195, or the antibody may contain a sequence selected from the sequences of SEQ ID NO:39 to SEQ ID NO:76. The antibody may be a monoclonal antibody. A method for treating or preventing an unwanted immune response disorder includes administering to a subject in need thereof an effective amount of an anti-granulysin antibody capable of neutralizing the activity of granulysin. The unwanted immune response disorder may be SJS, TEN, or GVHD.

Discover hidden collaborations